Literature DB >> 23434179

Human milk and related oligosaccharides as prebiotics.

Daniela Barile1, Robert A Rastall.   

Abstract

Human milk oligosaccharides (HMO) are believed to have a range of biological activities beyond providing nutrition to the infant. Principal among these is that they may act as prebiotics. Prebiotics are dietary ingredients, usually oligosaccharides that provide a health benefit to the host mediated by the modulation of the human gut microbiota. While it is clear that such oligosaccharides may have potential applications in infants and adults alike, this potential is limited by the difficulties in manufacturing HMO. Consequently functional alternatives such as galacto-oligosaccharides (GOS) are under investigation. GOS are produced enzymatically from lactose for commercial use in food applications--including addition to infant formulae--as similar to breast milk oligosaccharides, they encourage a gut bacteria population that promotes health and reduces the incidence of intestinal infections. New methods for separation and concentration of complex, breast milk-like oligosaccharides from bovine milk industrial streams that contain only low amounts of these valuable oligosaccharides are providing the opportunity to investigate other viable sources of specific oligosaccharides for use as prebiotics in supplements or food products.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23434179     DOI: 10.1016/j.copbio.2013.01.008

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  43 in total

Review 1.  α-L-Fucosidases and their applications for the production of fucosylated human milk oligosaccharides.

Authors:  Li Wan; Yingying Zhu; Wenli Zhang; Wanmeng Mu
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-01       Impact factor: 4.813

2.  Revisiting monosaccharide analysis - quantitation of a comprehensive set of monosaccharides using dynamic multiple reaction monitoring.

Authors:  Gege Xu; Matthew J Amicucci; Zhi Cheng; Ace G Galermo; Carlito B Lebrilla
Journal:  Analyst       Date:  2017-12-18       Impact factor: 4.616

3.  Executive summary: Evaluating the evidence base to support the inclusion of infants and children from birth to 24 mo of age in the Dietary Guidelines for Americans--"the B-24 Project".

Authors:  Daniel J Raiten; Ramkripa Raghavan; Alexandra Porter; Julie E Obbagy; Joanne M Spahn
Journal:  Am J Clin Nutr       Date:  2014-02-05       Impact factor: 7.045

4.  Absolute Quantitation of Human Milk Oligosaccharides Reveals Phenotypic Variations during Lactation.

Authors:  Gege Xu; Jasmine Cc Davis; Elisha Goonatilleke; Jennifer T Smilowitz; J Bruce German; Carlito B Lebrilla
Journal:  J Nutr       Date:  2016-10-19       Impact factor: 4.798

5.  Enzymatic synthesis of β-galactosyl fucose using recombinant bifidobacterial β-galactosidase and its prebiotic effect.

Authors:  So-Young Oh; Myeong-Soo Park; Yeong-Geun Lee; Nhan Nguyen Thi; Nam-In Baek; Geun-Eog Ji
Journal:  Glycoconj J       Date:  2019-04-27       Impact factor: 2.916

6.  Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice.

Authors:  Gaëlle Boudry; M Kristina Hamilton; Maciej Chichlowski; Saumya Wickramasinghe; Daniela Barile; Karen M Kalanetra; David A Mills; Helen E Raybould
Journal:  J Dairy Sci       Date:  2017-01-26       Impact factor: 4.034

7.  Cryogenic IR spectroscopy combined with ion mobility spectrometry for the analysis of human milk oligosaccharides.

Authors:  Neelam Khanal; Chiara Masellis; Michael Z Kamrath; David E Clemmer; Thomas R Rizzo
Journal:  Analyst       Date:  2018-04-16       Impact factor: 4.616

8.  Enzymatic synthesis of fucose-containing galacto-oligosaccharides using β-galactosidase and identification of novel disaccharide structures.

Authors:  Anne Usvalampi; Hannu Maaheimo; Olli Tossavainen; Alexander D Frey
Journal:  Glycoconj J       Date:  2017-09-13       Impact factor: 2.916

9.  Monobody-mediated alteration of enzyme specificity.

Authors:  Shun-Ichi Tanaka; Tetsuya Takahashi; Akiko Koide; Satoru Ishihara; Satoshi Koikeda; Shohei Koide
Journal:  Nat Chem Biol       Date:  2015-08-31       Impact factor: 15.040

Review 10.  The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease.

Authors:  Duane R Wesemann; Cathryn R Nagler
Journal:  Immunity       Date:  2016-04-19       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.